Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

BMYBMY
Showing 8 of 31 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in Bristol-Myers Squibb Co

AQR CAPITAL MANAGEMENT LLC holds 27.4M shares of BMY (Bristol-Myers Squibb Co), worth $1.6B as of 2026-Q2. The position was decreased (-7.7% shares). BMY represents 0.5% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$1.6B

Current Shares

27.4M

Total Value Change

+$1.4B

Total Shares Change

+23.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
27.4M
-7.7%
$1.6B0.5%$56.98
0
2026-Q1
Increased
29.6M
+14.9%
$1.8B0.8%$59.36
52
2025-Q4
Increased
25.8M
+172.6%
$1.4B0.7%$52.18
73
2025-Q3
Increased
9.5M
+56.0%
$426.4M0.3%$43.03
53
2025-Q2
Increased
6.1M
+1.7%
$280.7M0.2%$43.59
37
2025-Q1
Increased
6M
+49.0%
$364.1M0.4%$56.82
51
2024-Q4
Increased
4M
+2.7%
$226.6M0.3%$52.12
38
2024-Q3
Increased
3.9M
+45.7%
$200.5M0.3%$47.15
50

Other major holders of BMY: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used